AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metpride M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Assure Pharma

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Metpride M 1mg/500mg Tablet SR

Diabetam SR 1mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabetam SR with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical supervision can elevate blood glucose, increasing the risk of complications like nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Remember, this medication complements a comprehensive diabetes management plan, including dietary modifications, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. The most frequent adverse reaction is hypoglycemia (low blood sugar). Learn to identify symptoms—sweating, dizziness, headache, tremors—and manage them appropriately. Maintain regular mealtimes and carry a readily available fast-acting glucose source, such as glucose tablets or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Other possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of cardiovascular disease to your physician before commencing treatment, as it may be unsuitable. Pregnant or lactating women should seek medical counsel prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Metpride M 1mg/500mg Tablet SR

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Metpride M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Metpride M 1mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metpride M 1mg/500mg sustained-release tablet should be taken with a meal.

Common Side effects of Metpride M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Metpride M 1mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metpride M 1mg/500mg sustained-release tablet should be taken with a meal.

How Metpride M 1mg/500mg Tablet SR works:

Metformin/Glimepiride 500mg/1mg Extended-Release Tablets (Metpride M) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Metpride M 1mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Metpride M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Metpride M tablets (1mg/500mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with both hypo- and hyperglycemia. Refrain from driving if such symptoms manifest.

KidneyKidneyCAUTION

Patients with kidney impairment should use Metpride M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is necessary. Metpride M 1mg/500mg SR tablets are contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Metpride M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Metpride M 1mg/500mg Tablet SR :

Should you forget a Metpride M 1mg/500mg SR Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metpride M 1mg/500mg Tablet SR

LabelValue
Developing Good Habits No.
Treatment Category Diabetes Management

FAQs on Metpride M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Metpride M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Metpride M 1mg/500mg Tablet SR and seek immediate medical attention.
Metpride M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Metpride M 1mg/500mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Metpride M 1mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Metpride M 1mg/500mg Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Metpride M 1mg/500mg SR tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Metpride M 1mg/500mg Tabl...
48
MRP 55
12% off